APS and SPR honor Dr. Wendy K. Chung with the 2026 Mary Ellen Avery Neonatal Research Award
The American Pediatric Society (APS) and the Society for Pediatric Research (SPR) are pleased to announce Wendy K. Chung, MD, PhD, as the 2026 Mary Ellen Avery Neonatal Research Award recipient.
2025-10-14
(Press-News.org) HOUSTON, October 14, 2025 – The American Pediatric Society (APS) and the Society for Pediatric Research (SPR) are pleased to announce Wendy K. Chung, MD, PhD, as the 2026 Mary Ellen Avery Neonatal Research Award recipient. This award honors a pediatric investigator who has made important contributions to neonatal health through basic or translational research.
Dr. Wendy Chung, MD, PhD, is the Mary Ellen Avery Professor of Pediatrics, Chief of Pediatrics, and Pediatrician-in-Chief at Boston Children’s Hospital and Harvard Medical School. An internationally recognized leader in human genetics and genomics, she has advanced the understanding of congenital anomalies and transformed newborn screening, building on Dr. Avery’s pioneering legacy. Dr. Chung has discovered more than 60 genes for human disease—five bearing her name—and has led the integration of these discoveries into clinical practice through genetic testing, screening, and novel therapeutics. Her contributions have earned her some of the highest honors in medicine, including the Medal for Distinguished Contributions in Biomedical Science from the New York Academy of Medicine, the Rare Impact Award from the National Organization for Rare Disorders, and the Health Equity Award from Global Genes. She is a member of the National Academy of Medicine.
In 2013, the APS and SPR established and endowed the Mary Ellen Avery Award. This award honors Dr. Avery’s outstanding lifetime achievements and seminal contributions to neonatal health through her discovery of respiratory distress syndrome, research, academic leadership, and outstanding service to pediatrics and neonatology.
“The Mary Ellen Avery Neonatal Research Award is designed to honor an investigator who has made outstanding contributions to neonatal health. It is hard to imagine a more deserving recipient than Dr. Wendy Chung. Dr. Chung embodies the same values that represent the legacy of Dr. Avery. She has focused her research on the genetics of common neonatal disorders and, in particular, newborn screening. Dr. Chung’s research has had a major impact on clinical care and has improved health outcomes. She has been a leader in the use of whole exome and whole genome sequencing in the clinical care setting. Dr. Chung has served on the National Academy of Medicine committee to evaluate the use of genetic testing in clinical practice. Her work has improved care for children with congenital diaphragmatic hernia, congenital heart disease, and esophageal atresia. The American Pediatric Society is delighted to celebrate Dr. Chung’s many outstanding accomplishments as the recipient of the 2026 Mary Ellen Avery Award.”
— Dr. Stephen Daniels, President, American Pediatric Society
“The Society for Pediatric Research is honored to present the 2026 Mary Ellen Avery Award to Dr. Wendy K. Chung,” said Eric D. Austin, MD, MSc, President of the Society for Pediatric Research. “Dr. Chung is an internationally recognized leader in human genetics, including the genomics of congenital anomalies and innovative approaches to newborn screening, areas with significant impact on neonatology. She is an exemplary academic physician scientist whose research spans basic, translational, and clinical research while forging close partnerships with the public to improve child health. Dr. Chung exemplifies science-driven discovery for the immediate benefit of children with an extraordinary research productivity of over 800 peer reviewed publications and the successful completion of countless funded projects. She has identified over 60 novel genetic conditions and characterized their clinical phenotypes for research and clinical care. We are grateful for Dr. Chung’s contributions and celebrate her relentless pursuit of new knowledge.”
Dr. Chung received her PhD in human genetics from The Rockefeller University, her MD from Cornell University Medical College, and completed her fellowship in medical genetics at Columbia University. Dr. Chung has authored over 750 peer-reviewed publications in top journals including NEJM, JAMA, Nature, and Science, and has sustained continuous NIH funding for more than a decade. She is a member of the National Academy of Medicine and serves as editor of Fetal and Neonatal Physiology and Associate Editor of Rudolph’s Pediatrics.
For more information about Dr. Chung and the Mary Ellen Avery Award, please visit the APS website.
#
About the American Pediatric Society
The American Pediatric Society (APS) is a nonprofit organization founded in 1888 as the first pediatric society in North America. The mission of the APS is to engage distinguished child health leaders representing the full diversity within the field to shape the future of academic pediatrics. The 1,800 plus members of APS are recognized leaders of extraordinary achievement who work together to shape the future of academic pediatrics. For more information, please visit aps1888.org, and follow us on Facebook and Twitter.
About the Society for Pediatric Research
The Society for Pediatric Research (SPR) encourages and supports pediatric research endeavors by creating a network of diverse researchers to improve child health. Collaboration among SPR members creates meaningful progress for the future of children’s health. For more information, please visit www.societyforpediatricresearch.org, and follow us on Facebook and Twitter.
Media Contacts:
Lisa Thompson
Association Director
American Pediatric Society
(346) 258-6247
lthompson@aps1888.org
Liz Giannini
Association Director
Society for Pediatric Research
(346) 258-6257
liz.giannini@societyforpediatricresearch.org
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-10-14
The Gabriella Miller Kids First Data Resource Center (Kids First DRC) has launched the Variant Workbench, an innovative tool designed to dramatically accelerate research into childhood diseases.
For researchers studying genetic diseases, this new resource shifts the focus from the complex, time-consuming task of managing massive datasets to the core work of scientific exploration. The Variant Workbench functions as an interactive research environment within the cloud-based CAVATICA platform, essentially serving as a virtual lab bench for discovery.
Previously, ...
2025-10-14
Any life on Mars in the past, present, or future would have to contend with challenging conditions including, among others, shock waves from meteorite impacts and soil perchlorates—highly oxidizing salts that destabilize hydrogen bonds and hydrophobic interactions. Purusharth I. Rajyaguru and colleagues subjected Saccharomyces cerevisiae, which is a widely used model yeast, to shock waves and perchlorates. The authors chose the yeast in part because it has already been studied in space. When stressed, yeast, humans, and many other organisms form ribonucleoprotein ...
2025-10-14
Rechargeable batteries are a fundamental part of today's technological landscape, powering everything from our personal devices to large-scale infrastructure. While many types of rechargeable batteries exist, lithium-ion batteries (LIBs) are by far the most ubiquitous, owing to their outstanding energy density, long life cycle, and low self-discharge rate. However, lithium is rather a scarce element with a very uneven distribution throughout the world, prompting research into batteries made from other materials.
Over the past ...
2025-10-14
As the world strives to achieve carbon neutrality and slow down climate change, hydrogen has emerged as a promising fuel and energy carrier. Producing only water when consumed, hydrogen could help decarbonize industrial processes, power generation, and transportation. However, fulfilling this vision requires massive infrastructure—from high-pressure storage tanks to dedicated pipelines—that must withstand constant material stress due to the nature of hydrogen.
One of the biggest obstacles is hydrogen embrittlement. This is a complex phenomenon where metals, including ...
2025-10-14
GÖTTINGEN, Germany, 14 October 2025 -- Researchers led by Dr. Roberto Goya-Maldonado at the University Medical Center Göttingen have identified a rapid physiological marker that predicts which patients with major depression will respond to magnetic brain stimulation therapy. The peer-reviewed research article, published in Brain Medicine, found that patients whose heart rates slowed within 45 seconds of starting treatment showed significantly greater improvement in depressive symptoms six weeks later.
Uncovering ...
2025-10-14
OXFORD, Oxfordshire, UK, 14 October 2025 -- In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Najaf Amin unveils transformative insights that fundamentally reshape international understanding of depression genetics. The Oxford University Associate Professor, ranked among the top scientists globally in genetics and the top women in science worldwide, shares ground breaking discoveries that promise to revolutionize how researchers across continents approach major depression. With over 350 peer-reviewed publications and an exceptional h-index of 125, Dr. Amin has positioned herself at the vanguard of molecular epidemiology, challenging long-held ...
2025-10-14
CHIBA, JAPAN, 14 October 2025 -- A comprehensive peer-reviewed invited review published today in Psychedelics by Dr. Kenji Hashimoto and colleagues (Dr. Mingming Zhao and Dr. Jianjun Yang) synthesizes the evolving landscape of MDMA-assisted psychotherapy, examining robust clinical evidence in treatment-resistant posttraumatic stress disorder while identifying promising applications in autism spectrum disorder, eating disorders, and existential distress. The review traces the complex journey from early therapeutic promise ...
2025-10-14
CHANGCHUN, Jilin, CHINA, 14 October 2025 -- A peer-reviewed viewpoint article published today in Psychedelics by Prof. Xiaohui Wang and colleagues examines the therapeutic potential of psychedelic substances for treating stress-related psychiatric disorders through novel neurobiological mechanisms. The analysis synthesizes current evidence on how compounds like psilocybin, lysergic acid diethylamide (LSD), and MDMA could fundamentally alter treatment paradigms for depression, anxiety, and posttraumatic stress disorder (PTSD).
Addressing Chronic Stress Impact
The authors emphasize that chronic stress represents a major contributor to psychiatric illness worldwide, with persistent ...
2025-10-14
BELMONT, Massachusetts, USA, 14 October 2025 -- In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Bruce M. Cohen discusses results and insights that are reshaping international approaches to understanding and treating neuropsychiatric disorders. The Robertson-Steele Professor of Psychiatry at Harvard Medical School and Director of the Program for Neuropsychiatric Research at McLean Hospital shares remarkable discoveries from nearly five decades of groundbreaking research and places them in the context of a growing evidence base that can reshape psychiatric practice ...
2025-10-14
Note to reporters: An embargoed video explaining the research is available for preview at https://youtu.be/E5hDhWSmeoY. The mother featured in the video is available for media interviews.
Hearing the sound of their mother’s voice promotes development of language pathways in a premature baby’s brain, according to a new Stanford Medicine-led study.
During the study, which is publishing online Oct. 13 in Frontiers in Human Neuroscience, hospitalized preemies regularly heard recordings of their mothers reading to them. At the end of the study, MRI brain scans showed that a key language pathway was more mature than that of preemies in a control group who did not ...
LAST 30 PRESS RELEASES:
[Press-News.org] APS and SPR honor Dr. Wendy K. Chung with the 2026 Mary Ellen Avery Neonatal Research Award
The American Pediatric Society (APS) and the Society for Pediatric Research (SPR) are pleased to announce Wendy K. Chung, MD, PhD, as the 2026 Mary Ellen Avery Neonatal Research Award recipient.
